# DNAnexus

> DNAnexus provides a cloud platform for managing, analyzing and sharing genomic, multi-omic and clinical data. Pharmaceutical companies, diagnostic laboratories, biobanks and research institutions use its workflows, cohort tools and governed workspaces to conduct biomedical research at scale.

- **Founded:** 2009
- **Headquarters:** Mountain View, United States
- **Founders:** Andreas Sundquist (Co-founder; founding CEO), Arend Sidow (Co-founder), Serafim Batzoglou (Co-founder)
- **Products:** DNAnexus Platform, UK Biobank Research Analysis Platform, precisionFDA infrastructure, Omics Data Agent, AutoML Assistant
- **Notable:** Developed the UK Biobank Research Analysis Platform, opened to the wider research community in 2021., Powers precisionFDA, launched by the FDA in 2015., DNAnexus Platform listed as FedRAMP Certified, Class C (Moderate), certified since October 15, 2018.

## Products & services

- **DNAnexus Platform** — Cloud data management, bioinformatics workflows, cohort exploration, notebooks, access controls and scientific collaboration.
- **UK Biobank Research Analysis Platform** — A UK-hosted AWS research environment developed for approved analysis of UK Biobank biomedical data; general researcher launch in 2021. New applications were paused on the July 2026 access page.
- **precisionFDA infrastructure** — DNAnexus powers the FDA collaborative cloud environment for testing, benchmarking and regulatory science.
- **Omics Data Agent** — A generative AI conversational interface for cohort creation, dataset summaries and longitudinal queries.
- **AutoML Assistant** — Conversational assistance for prototyping and refining machine-learning models.
- **Omics Data Catalog** — Governed metadata management to make scientific datasets discoverable, comparable and reusable.
- **Professional Services** — Scientific and engineering support for pipelines, integrations, custom environments and platform implementation.

## Achievements

- Developed the UK Biobank Research Analysis Platform, opened to the wider research community in 2021.
- Powers precisionFDA, launched by the FDA in 2015.
- DNAnexus Platform listed as FedRAMP Certified, Class C (Moderate), certified since October 15, 2018.
- Reported 135+ petabytes of omics data, 64,000+ researchers and 130+ enterprise customers in August 2026.
- Announced inclusion in the 2026 Inc. 5000 list.

## Latest updates

- **2026-05** — Announced Omics Data Agent, AutoML Assistant, Omics Data Catalog and new solution packages.
- **2026-06** — UK Biobank’s oversight report described gaps in export checking and the need for an Output Checking System after data misuse.
- **2026-07** — DNAnexus reported 90% positive support CSAT responses; its methodology notes a roughly 12% survey response rate.
- **2026-07** — UK Biobank’s access page stated new applications were paused, with a planned return in late 2026.
- **2026-08** — DNAnexus announced inclusion in the 2026 Inc. 5000 list.

## Links

- Website: https://www.dnanexus.com/
- LinkedIn: https://www.linkedin.com/company/dnanexus/
- Twitter/X: https://x.com/dnanexus
- GitHub: https://github.com/dnanexus
- YouTube: https://www.youtube.com/@Dnanexus
- Facebook: https://www.facebook.com/pages/DNAnexus/223138427780595

---

Profile page: https://yespress.io/dnanexus
Published by YesPress — https://yespress.io
Last updated: 2026-10-02